There is no cure for fibromyalgia. No medication, surgery, or therapy can eliminate the condition entirely. But that doesn’t mean the outlook is hopeless. About 25% of people with fibromyalgia experience moderate to substantial improvement in pain over time, and a combination of medication, exercise, and lifestyle changes can make the condition significantly more manageable for many others.
Fibromyalgia affects roughly 2% to 8% of the global population. Women are diagnosed more often than men, though newer diagnostic criteria using symptom questionnaires rather than physical tender-point exams have narrowed that gap considerably. A large population survey using updated criteria found a female-to-male ratio closer to 6:4, far less skewed than the older 9:1 estimates.
Why Fibromyalgia Is So Hard to Cure
Fibromyalgia is now understood as a neurosensory disorder, meaning the problem isn’t damaged muscles or joints but rather how the central nervous system processes pain signals. Your brain and spinal cord essentially turn up the volume on pain, making normal sensations feel painful and painful sensations feel worse. This process is called central sensitization.
Several measurable chemical imbalances drive this. People with fibromyalgia have excess levels of substance P, a chemical messenger that amplifies pain signals, and elevated glutamate in brain regions involved in pain perception. At the same time, they have lower levels of serotonin and norepinephrine, chemicals that normally act as the body’s built-in pain-dampening system. Nerve growth factor, which increases the production of substance P, has been found at four times the normal level in the spinal fluid of fibromyalgia patients. Dopamine signaling in the brain’s emotional and reward centers also appears to be disrupted.
Because so many overlapping systems are involved, there’s no single target a drug or treatment can hit to switch off the condition. Genetic variation also plays a role. Researchers have identified patterns in specific gene variants that influence neurotransmitter and receptor levels in the brain, helping explain why fibromyalgia runs in families and why individuals respond so differently to the same treatments.
What Long-Term Improvement Actually Looks Like
A study tracking 1,555 fibromyalgia patients over time found that about 10% experienced substantial improvement, defined as a 50% or greater reduction in symptom severity. Another 14% saw moderate but clinically meaningful improvement. That means roughly one in four people got noticeably better. However, the picture isn’t uniformly positive: symptoms worsened in about 36% of patients, and overall averages didn’t shift much. Fibromyalgia tends to be a long-term condition that fluctuates rather than one that steadily improves or steadily declines.
Complete remission, where someone no longer meets diagnostic criteria at all, is uncommon but not unheard of. Even among those who improved moderately, 43% still technically met the diagnostic threshold for fibromyalgia. The realistic goal for most people is reducing pain and fatigue to a level that allows fuller participation in daily life, not eliminating symptoms entirely.
Medications That Help Manage Symptoms
Four medications are now FDA-approved specifically for fibromyalgia. Three have been available for years: pregabalin, which calms overactive nerve signaling; duloxetine and milnacipran, which boost serotonin and norepinephrine to strengthen the body’s natural pain-suppression pathways. The newest addition is a sublingual form of cyclobenzaprine, a muscle relaxant that dissolves under the tongue at bedtime. In clinical trials, it reduced daily pain scores significantly more than placebo over 14 weeks, with average pain dropping by about 1.8 to 1.9 points on a 10-point scale compared to 1.2 to 1.5 for placebo.
None of these medications eliminate fibromyalgia pain. They typically reduce it by 30% to 50% in the people who respond well, and a meaningful percentage of patients don’t respond to any of them. Most doctors try different options or combinations to find what works for an individual. Side effects, which vary by drug, often determine which medication is worth continuing.
Exercise as a Core Treatment
Aerobic exercise is one of the most consistently effective interventions for fibromyalgia, often matching or exceeding the benefit of medication. The challenge is that the very symptoms it treats, pain and fatigue, make it difficult to start and sustain.
A large meta-analysis identified the most effective prescription: moderate-intensity, water-based aerobic exercise performed for 60 minutes per session, once or twice a week, over 12 to 16 weeks. Pool-based exercise works particularly well because warm water reduces joint stress and muscle tension while you move. The optimal weekly “dose” was about 470 MET-minutes per week, roughly equivalent to 90 minutes of brisk walking or 60 minutes of water aerobics. Importantly, the effective range was broad, from 75 to 750 MET-minutes per week, meaning even light activity provides measurable pain relief.
Starting low and building slowly is key. Pushing too hard too fast triggers symptom flares that can set you back. Many people do best starting with 10 to 15 minutes of gentle movement and gradually increasing over weeks.
The Gut-Brain Connection
Research has found that people with fibromyalgia have a measurably different composition of gut bacteria compared to healthy individuals. Specifically, bacteria involved in producing butyrate, a short-chain fatty acid that helps regulate inflammation and supports nervous system function, are consistently altered. Blood tests confirm that fibromyalgia patients have different circulating levels of butyrate and other metabolic byproducts of gut bacteria.
This doesn’t yet translate into a treatment. No specific probiotic or dietary intervention has been proven to improve fibromyalgia symptoms in rigorous trials. But it opens a biological pathway that may eventually explain why some people develop fibromyalgia and others don’t, and it’s one of the more active areas of investigation.
Experimental Approaches Under Study
Low-dose naltrexone has generated significant interest among fibromyalgia patients and some clinicians. At very low doses, this medication (originally used for addiction treatment) is thought to reduce neuroinflammation. However, the largest randomized trial to date, published in The Lancet Rheumatology, was disappointing. Among 99 women with fibromyalgia, those taking low-dose naltrexone experienced a 1.3-point reduction in pain versus 0.9 points for placebo. The difference was not statistically significant. Side effect rates were similar between groups. Some smaller studies have shown more promising results, so interest hasn’t disappeared, but the evidence is far from settled.
Repetitive transcranial magnetic stimulation, a technique that uses magnetic pulses to modulate brain activity, is being tested in clinical trials targeting the left prefrontal cortex, a brain region involved in pain processing and mood regulation. Early-stage trials are evaluating whether sessions can reduce pain, fatigue, and cognitive difficulties. Results are still emerging, and the treatment remains experimental for fibromyalgia.
What Actually Works Best
The most effective approach to fibromyalgia combines multiple strategies rather than relying on any single one. Medication addresses the chemical imbalances in pain processing. Regular moderate exercise, particularly in warm water, retrains the nervous system and reduces pain sensitivity over time. Cognitive behavioral therapy helps break the cycle of pain catastrophizing and poor sleep that amplifies symptoms. Sleep improvement, whether through medication, behavioral changes, or both, is often the single most impactful intervention because disrupted sleep directly worsens pain sensitivity.
This multimodal approach won’t cure fibromyalgia. But for the majority of people, it can shift the condition from something that dominates daily life to something that sits more in the background. The 25% who improve substantially tend to be those who find the right combination and sustain it over months and years, not those who find a single breakthrough treatment.